Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4–20.

Article  PubMed  Google Scholar 

Coyne K, Payne C, Bhattacharyya S, Revicki D, Thompson C, Corey R, Hunt T. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health J Int Soc Pharmacoecon Outcomes Res. 2004;7:455–63.

Article  Google Scholar 

Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–15.

Article  PubMed  Google Scholar 

Stewart W, Rooyen JV, Cundiff G, Abrams P, Herzog A, Corey R, Hunt T, Wein A. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–36.

Article  CAS  PubMed  Google Scholar 

Coyne KS, Wein A, Nicholson S, Kvasz M, Chen C-I, Milsom I. Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm. 2014;20:130–40.

PubMed  Google Scholar 

Elstad EA, Taubenberger SP, Botelho EM, Tennstedt SL. Beyond incontinence: the stigma of other urinary symptoms. J Adv Nurs. 2010;66:2460–70.

Article  PubMed  PubMed Central  Google Scholar 

Aoki Y, Brown H, Brubaker L, Cornu J, Daly J, Cartwright R. Urinary incontinence in women. Nat Rev Dis Primers. 2017;3:17042.

Article  PubMed  PubMed Central  Google Scholar 

D’Ancona C, Haylen B, Oelke M, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38:433–77.

Article  PubMed  Google Scholar 

Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol. 2019;202:558–63.

Article  PubMed  Google Scholar 

Moskowitz D, Adelstein SA, Lucioni A, Lee UJ, Kobashi KC. Use of third line therapy for overactive bladder in a practice with multiple subspecialty providers—are we doing enough? J Urol. 2018;199:779–84.

Article  PubMed  Google Scholar 

OCEBM Levels of Evidence Working Group. The Oxford 2011 levels of evidence. Oxford Centre for Evidence-Based Medicine. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence. Accessed 22 Apr 2024

Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32:11–8.

Article  PubMed  Google Scholar 

de Groat WC. A neurologic basis for the overactive bladder. Urology. 1997;50:36–52.

Article  PubMed  Google Scholar 

Al-Danakh A, Safi M, Alradhi M, Almoiliqy M, Chen Q, Al-Nusaif M, Yang X, Al-Dherasi A, Zhu X, Yang D. Posterior tibial nerve stimulation for overactive bladder: mechanism, classification, and management outlines. Parkinson’s Dis. 2022;2022:2700227.

Google Scholar 

Li X, Li X, Liao L. Mechanism of action of tibial nerve stimulation in the treatment of lower urinary tract dysfunction. Neuromodul Technol Neural Interface. 2023. https://doi.org/10.1016/j.neurom.2023.03.017.

Article  Google Scholar 

Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. J Urol. 1988;140:1331–9.

Article  CAS  PubMed  Google Scholar 

Schmidt RA, Jonas U, Oleson KA, Janknegt RA, Hassouna MM, Siegel SW, van Kerrebroeck PEV, van KPEV. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. J Urol. 1999;162:352–7.

Article  CAS  PubMed  Google Scholar 

Cooperberg M, Stoller M. Percutaneous neuromodulation. Urol Clin N Am. 2005;32(71–8):vii.

Google Scholar 

Tai C, Shen B, Chen M, Wang J, Roppolo JR, de Groat WC. Prolonged poststimulation inhibition of bladder activity induced by tibial nerve stimulation in cats. Am J Physiol-Ren Physiol. 2011;300:F385–92.

Article  CAS  Google Scholar 

Choudhary M, Mastrigt R, Asselt E. Effect of tibial nerve stimulation on bladder afferent nerve activity in a rat detrusor overactivity model. Int J Urol. 2016;23:253–8.

Article  PubMed  Google Scholar 

Choudhary M, van Mastrigt R, van Asselt E. Inhibitory effects of tibial nerve stimulation on bladder neurophysiology in rats. Springerplus. 2016;5:35.

Article  PubMed  PubMed Central  Google Scholar 

Bhide AA, Tailor V, Fernando R, Vik K, Digesu GA. Posterior tibial nerve stimulation for overactive bladder—techniques and efficacy. Int Urogynecol J. 2020;31:865–70.

Article  PubMed  Google Scholar 

Rahnamai MS. Neuromodulation for functional bladder disorders in patients with multiple sclerosis. Mult Scler J. 2020;26:1274–80.

Article  Google Scholar 

Kobashi K, Nitti V, Margolis E, Sand P, Siegel S, Khandwala S, Newman D, MacDiarmid SA, Kan F, Michaud E. A prospective study to evaluate efficacy using the nuro percutaneous tibial neuromodulation system in drug-naïve patients with overactive bladder syndrome. Urology. 2019;131:77–82.

Article  PubMed  Google Scholar 

Harding, Lapitan M, Arlandis S et al (2023) EAU guidelines on management of non-neurogenic female lower urinary tract symptoms. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-neurogenic-Female-LUTS-2023.pdf.

Chermansky C, Schurch B, Rahnamai M, Averbeck M, Malde S, Mancini V, Valentini F, Sahai A. How can we better manage drug-resistant OAB/DO? ICI-RS 2018. Neurourol Urodyn. 2019;38(Suppl 5):S46–55.

PubMed  Google Scholar 

Marcelissen T, Cornu J-N, Antunes-Lopes T, Geavlete B, Delongchamps NB, Rashid T, Rieken M, Rahnama’i MS. Management of idiopathic overactive bladder syndrome: what is the optimal strategy after failure of conservative treatment? [Figure presented]. Eur Urol Focus. 2018;4:760–7.

Article  PubMed  Google Scholar 

Apostolidis A, Averbeck M, Sahai A, Rahnama’i M, Anding R, Robinson D, Gravas S, Dmochowski R. Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015). Neurourol Urodyn. 2017;36:882–93.

Article  PubMed  Google Scholar 

Gordon T, Merchant M, Ramm O, Patel M. Factors associated with long-term use of percutaneous tibial nerve stimulation for management of overactive bladder syndrome. Female Pelvic Med Reconstr Surg. 2021;27:444–9.

Article  PubMed  Google Scholar 

Jung CE, Menefee SA, Diwadkar GB. Percutaneous tibial nerve stimulation maintenance therapy for overactive bladder in women: long-term success rates and adherence. Int Urogynecol J. 2021;32:617–25.

Article  PubMed  Google Scholar 

te DMJ, J.P.F.A. H, van BMR. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients. Neurourol Urodyn. 2020;39:702–6.

Chapple CR, Nazir J, Hakimi Z, Bowditch S, Fatoye F, Guelfucci F, Khemiri A, Siddiqui E, Wagg A. Persistence and adherence with mirabegron versus antimuscarinic agents in patients with overactive bladder: a retrospective observational study in UK clinical practice. Eur Urol. 2017;72:389–99.

Article  CAS  PubMed  Google Scholar 

Yeowell G, Smith P, Nazir J, Hakimi Z, Siddiqui E, Fatoye F. Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review. BMJ Open. 2018. https://doi.org/10.1136/bmjopen-2018-021889.

Article  PubMed  PubMed Central  Google Scholar 

Michel MC, Cardozo L, Chermansky CJ, Cruz F, Igawa Y, Lee K-S, Sahai A, Wein AJ, Andersson K-E. Current and emerging pharmacological targets and treatments of urinary incontinence and related disorders. Pharmacol Rev. 2023;75:PHARMREV-AR-2021-000523.

eCoin summary of safety and effectiveness data. https://www.accessdata.fda.gov/cdrh_docs/pdf20/P200036B.pdf. Accessed 1 Dec 2023.

eCoin physician manual. https://www.accessdata.fda.gov/cdrh_docs/pdf20/P200036D.pdf. Accessed 1 Dec 2023.

ReviTM patient therapy guide. https://bluewindmedical.com/wp-content/uploads/2023/10/revi-patient-therapy-guide.pdf. Accessed 28 Nov 2023.

Rogers A, Bragg S, Ferrante K, Thenuwara C, Peterson DKL. Pivotal study of leadless tibial nerve stimulation with eCoin® for urgency urinary incontinence: an open-label, single arm trial. J Urol. 2021;206:399–408.

Article  PubMed  Google Scholar 

Lee UJ, Xavier K, Benson K, et al. Rationale and design of an implant procedure and pivotal study to evaluate safety and effectiveness of Medtronic’s tibial neuromodulation device. Contemp Clin Trials Commun. 2023;35: 101198.

Article  PubMed  PubMed Central  Google Scholar 

Govier F, Litwiller S, Nitti V, Kreder Jr K, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165:1193–8.